首页> 美国卫生研究院文献>Nucleic Acids Research >Gene integrated set profile analysis: a context-based approach for inferring biological endpoints
【2h】

Gene integrated set profile analysis: a context-based approach for inferring biological endpoints

机译:基因整合的集合概况分析:推断生物学终点的基于上下文的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The identification of genes with specific patterns of change (e.g. down-regulated and methylated) as phenotype drivers or samples with similar profiles for a given gene set as drivers of clinical outcome, requires the integration of several genomic data types for which an ‘integrate by intersection’ (IBI) approach is often applied. In this approach, results from separate analyses of each data type are intersected, which has the limitation of a smaller intersection with more data types. We introduce a new method, GISPA (Gene Integrated Set Profile Analysis) for integrated genomic analysis and its variation, SISPA (Sample Integrated Set Profile Analysis) for defining respective genes and samples with the context of similar, a priori specified molecular profiles. With GISPA, the user defines a molecular profile that is compared among several classes and obtains ranked gene sets that satisfy the profile as drivers of each class. With SISPA, the user defines a gene set that satisfies a profile and obtains sample groups of profile activity. Our results from applying GISPA to human multiple myeloma (MM) cell lines contained genes of known profiles and importance, along with several novel targets, and their further SISPA application to MM coMMpass trial data showed clinical relevance.
机译:鉴定具有特定变化模式(例如下调和甲基化)的基因作为表型驱动因素或给定基因组的具有相似特征的样品作为临床结果的驱动因素,需要整合几种基因组数据类型,交叉路口(IBI)方法经常被采用。在这种方法中,将每种数据类型的单独分析结果相交,这具有较小的交集和更多数据类型的局限性。我们介绍了一种用于集成基因组分析及其变异的新方法GISPA(基因集成集概况分析),用于定义具有相似先验指定分子概况的背景下的各个基因和样品的SISPA(样品集成集概况分析)。使用GISPA,用户可以定义在多个类别之间进行比较的分子概况,并获得满足该概况的排名基因集作为每个类别的驱动力。使用SISPA,用户可以定义一个满足轮廓并获得轮廓活性的样本组的基因集。我们将GISPA应用于人类多发性骨髓瘤(MM)细胞系的结果包含已知谱型和重要性的基因,以及一些新的靶标,并将它们进一步应用于SIMM的coMMpass试验数据显示出临床相关性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号